A new federal lawsuit is challenging Texas officials' decision to treat delta-8 and other non-delta-9 THC isomers as Schedule I controlled substances. The filing arrives as the state's restored definitions took effect July 31, exposing businesses and consumers to potential enforcement while the challengers seek emergency court relief.
WFAA reports that three plaintiffs filed the federal challenge and requested emergency relief. The lawsuit does not itself suspend the Texas schedule; a court would have to grant relief before the current enforcement position changes.
What the New Lawsuit Claims
The challengers argue that Texas officials cannot criminalize hemp-derived cannabinoids that Congress removed from federal controlled-substance treatment in the 2018 Farm Bill, provided the material meets the federal definition of hemp. They also contend that the state action conflicts with Texas's 2019 hemp law and violates constitutional protections involving due process and interstate commerce.
Those are allegations, not court findings. At publication, CannaWize had not independently reviewed a publicly posted copy of the new federal complaint or an order assigning a case number. The plaintiffs' names, the court, and the precise requested injunction should be confirmed from the docket before being treated as settled details. CannaWize will update this report when the filing is publicly available.
Why Texas Says the Products Are Controlled
The Texas Department of State Health Services says its reinstated Schedule I definitions became effective July 31. The agency's position covers manufactured or converted delta-8 and other THC isomers while preserving an exception for hemp containing no more than 0.3% delta-9 THC by dry weight.
That action followed the Texas Supreme Court's May 1 decision in Texas Department of State Health Services v. Sky Marketing Corp. The court held that the state health commissioner retained authority to object to federal scheduling changes and that the prior state-court injunction could not stand. The ruling cleared the procedural path for Texas to restore its 2021 definitions, but the new federal case raises a different mix of preemption and constitutional arguments.
What This Means Right Now
Retailers should not return affected products to shelves based only on news of the lawsuit. Until a court issues an order or the state changes its guidance, businesses face the enforcement position described in CannaWize's July 31 delta-8 rule report. Product labels, batch testing, sourcing records, and cannabinoid-specific legal review remain essential.
Consumers should also avoid treating "hemp-derived" as a complete legal conclusion. The state's current position distinguishes compliant delta-9 hemp from manufactured delta-8 and other isomers, while smokeable-hemp restrictions remain part of a separate rule dispute. Possession risk can turn on the product's actual chemistry, how it was made, and how local authorities apply the schedule.
What Happens Next
The immediate question is whether the federal judge grants a temporary restraining order or preliminary injunction. Courts considering that relief generally examine likely success on the merits, irreparable harm, the balance of harms, and the public interest. A denial would not necessarily end the lawsuit, but it would leave current enforcement in place while the case continues.
The state defendants will have an opportunity to respond, and jurisdictional questions may come first. The dispute also sits against a changing federal backdrop: Congress enacted a narrower federal hemp definition scheduled to take effect in November 2026. Readers can follow the broader conflict in CannaWize's federal-versus-state cannabis law explainer.